Metrion Biosciences
Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug discovery.
Latest Content
Product News
Metrion Biosciences Launches NaV1.9 High-Throughput Screening Assay To Strengthen Screening Portfolio
Metrion Biosciences launches a validated NaV1.9 screening assay to advance non-opioid pain therapeutic development.
Product News
Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries
Access to compound collection enables greater flexibility and efficiencies in screening and target identification.
Advertisement
